| P2093 | author name string | Sanjiv S Gambhir | |
| | Avnesh S Thakor | |
| P2860 | cites work | Nanoparticle technologies for cancer therapy | Q37706288 |
| | Mifamurtide: a review of its use in the treatment of osteosarcoma | Q37756110 |
| | Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. | Q37780545 |
| | Remotely triggerable drug delivery systems | Q37785501 |
| | Potential clinical applications of siRNA technique: benefits and limitations | Q37801965 |
| | In vivo targeted delivery of nanoparticles for theranosis | Q37919504 |
| | Photodynamic therapy (PDT) for lung cancer | Q37921914 |
| | Iron oxide nanoparticles for targeted cancer imaging and diagnostics. | Q37935197 |
| | Gold nanorods as molecular contrast agents in photoacoustic imaging: the promises and the caveats | Q37949293 |
| | Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review | Q37960507 |
| | Photodynamic therapy: current evidence and applications in dermatology | Q37962177 |
| | Tunable nanostructures as photothermal theranostic agents | Q37963732 |
| | Nanoparticles as computed tomography contrast agents: current status and future perspectives | Q37984484 |
| | Clinical development of new formulations of cytotoxics in solid tumors | Q37985477 |
| | Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy | Q37989502 |
| | Targeting carbon nanotubes against cancer. | Q37994689 |
| | Doxil®--the first FDA-approved nano-drug: lessons learned | Q38000876 |
| | Theranostic applications of nanoparticles in cancer | Q38000924 |
| | Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy | Q38024630 |
| | Biologically responsive polymeric nanoparticles for drug delivery. | Q38044396 |
| | Hyperthermia-induced drug targeting | Q38071664 |
| | A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. | Q38747485 |
| | A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle | Q24615790 |
| | The fate and toxicity of Raman-active silica-gold nanoparticles in mice. | Q24626480 |
| | Gold nanoprobes for theranostics | Q24629197 |
| | Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy | Q24651971 |
| | Quantum dots for live cell and in vivo imaging | Q24653011 |
| | Noninvasive molecular imaging of small living subjects using Raman spectroscopy | Q24653843 |
| | Drug delivery and nanoparticles:applications and hazards | Q24655744 |
| | Carbon nanotubes as photoacoustic molecular imaging agents in living mice. | Q24657130 |
| | Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 |
| | Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain | Q28179415 |
| | A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent | Q28287436 |
| | Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens | Q28390624 |
| | Plasmonic photothermal therapy (PPTT) using gold nanoparticles | Q29397114 |
| | Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 |
| | The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 |
| | Cancer nanotechnology: opportunities and challenges | Q29615481 |
| | Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles | Q29615957 |
| | In vivo cancer targeting and imaging with semiconductor quantum dots | Q29617278 |
| | Drug delivery systems: entering the mainstream | Q29618136 |
| | Requirement of vascular integrin alpha v beta 3 for angiogenesis | Q29619681 |
| | Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics | Q30421483 |
| | Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice | Q30453141 |
| | Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. | Q30457900 |
| | Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods | Q30457905 |
| | Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons | Q30475616 |
| | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release | Q30478123 |
| | Molecular photoacoustic tomography with colloidal nanobeacons | Q30481075 |
| | Design considerations for tumour-targeted nanoparticles | Q30492525 |
| | The preferential targeting of the diseased microvasculature by disk-like particles | Q30515715 |
| | Optical properties and ultrafast dynamics of metallic nanocrystals. | Q30894030 |
| | Single-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinoma. | Q30990427 |
| | Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). | Q50020682 |
| | Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. | Q50471623 |
| | Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. | Q50896680 |
| | Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. | Q51190042 |
| | Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. | Q51505381 |
| | How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system? | Q51623682 |
| | Developmental biology, self-renewal, and cancer. | Q51984442 |
| | Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. | Q52302546 |
| | Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. | Q52925886 |
| | Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. | Q53401747 |
| | Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. | Q53563312 |
| | Quantum dot bioconjugates for ultrasensitive nonisotopic detection. | Q54135557 |
| | FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). | Q54435146 |
| | Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains | Q56443622 |
| | Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation | Q57662899 |
| | Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles | Q58215486 |
| | CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical Development | Q35237593 |
| | In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice | Q35254435 |
| | Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting | Q35553201 |
| | Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. | Q35572430 |
| | Solid lipid nanoparticles for parenteral drug delivery. | Q35756600 |
| | Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles | Q35788462 |
| | Molecular imaging applications in nanomedicine. | Q35867032 |
| | Cationic liposomes for gene delivery | Q36316712 |
| | Targeting intracellular targets | Q36320723 |
| | Ligand-targeted liposomes for cancer treatment | Q36320811 |
| | Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma | Q36369051 |
| | Challenges and opportunities in the advancement of nanomedicines | Q36417295 |
| | Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma | Q36614855 |
| | Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine | Q36629939 |
| | Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology | Q36656404 |
| | Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma | Q36687568 |
| | RNA interference: implications for cancer treatment | Q36738853 |
| | Liposomal Doxorubicin in the treatment of breast cancer patients: a review | Q36748268 |
| | Photodynamic therapy for pancreatic cancer | Q36796863 |
| | Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors | Q36883859 |
| | Drug delivery with carbon nanotubes for in vivo cancer treatment | Q36925878 |
| | The effect of particle design on cellular internalization pathways | Q36954579 |
| | Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers | Q37117418 |
| | Rationally designed nanostructures for surface-enhanced Raman spectroscopy | Q37149951 |
| | Multistage nanoparticles for improved delivery into tumor tissue | Q37176313 |
| | Nanoparticles in photodynamic therapy: an emerging paradigm | Q37302245 |
| | Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products | Q37320828 |
| | Knocking down barriers: advances in siRNA delivery | Q37380671 |
| | Nanomedicine: perspective and promises with ligand-directed molecular imaging | Q37408545 |
| | Nanoparticles in cellular drug delivery | Q37418471 |
| | Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage | Q37582220 |
| | Properties and emerging applications of self-assembled structures made from inorganic nanoparticles | Q37662193 |
| | Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds | Q37680425 |
| | Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy | Q31035862 |
| | Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. | Q33223686 |
| | Hollow silica spheres with an ordered pore structure and their application in controlled release studies. | Q33227819 |
| | Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles | Q33239851 |
| | Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy | Q33272799 |
| | Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma | Q33342849 |
| | A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer | Q33395752 |
| | Shuttling gold nanoparticles into tumoral cells with an amphipathic proline-rich peptide | Q33422381 |
| | The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles | Q33517197 |
| | Spatiotemporal controlled delivery of nanoparticles to injured vasculature | Q33529582 |
| | Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance | Q33578774 |
| | cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. | Q33834952 |
| | Resistance mechanisms associated with altered intracellular distribution of anticancer agents. | Q33876883 |
| | Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease | Q34068220 |
| | Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy | Q34144807 |
| | Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast | Q34145477 |
| | Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. | Q34227677 |
| | The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting | Q34268743 |
| | Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer | Q34302904 |
| | First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies | Q34327123 |
| | Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy | Q34328569 |
| | Nanomedicine: current status and future prospects. | Q34399915 |
| | The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma | Q34471154 |
| | The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. | Q34473470 |
| | Multistage nanoparticle delivery system for deep penetration into tumor tissue | Q34572820 |
| | Transferrin/transferrin receptor-mediated drug delivery. | Q34587503 |
| | Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration | Q34634591 |
| | Molecular basis for target RNA recognition and cleavage by human RISC. | Q34654514 |
| | Tumors and inflammatory infiltrates: friends or foes? | Q34687554 |
| | The cellular and molecular basis of hyperthermia | Q34721242 |
| | Delivering nanomedicine to solid tumors | Q34726981 |
| | Nanoparticles in cancer therapy and diagnosis | Q34804817 |
| | Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities | Q35058921 |
| | Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy | Q35090262 |
| | Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs. | Q39332859 |
| | Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma | Q39367525 |
| | Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. | Q39386667 |
| | Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy | Q39473930 |
| | Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles | Q39622805 |
| | Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. | Q39641011 |
| | Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers | Q39738503 |
| | Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy | Q39752105 |
| | Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model | Q39792777 |
| | Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin | Q39805519 |
| | Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 |
| | Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy | Q39975016 |
| | Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature | Q40066441 |
| | Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. | Q40100698 |
| | The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. | Q40178912 |
| | Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. | Q40266743 |
| | Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway | Q40340698 |
| | Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments | Q40371100 |
| | Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. | Q40371108 |
| | Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. | Q40377022 |
| | In vitro and in vivo activities of verteporfin-loaded nanoparticles. | Q40458398 |
| | Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery | Q40518809 |
| | Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody | Q41065057 |
| | Incorporation of the model drug ubidecarenone into solid lipid nanoparticles | Q41630859 |
| | Nanoparticle self-assembly gated by logical proteolytic triggers | Q42017561 |
| | Challenge in Understanding Size and Shape Dependent Toxicity of Gold Nanomaterials in Human Skin Keratinocytes | Q42041255 |
| | Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 |
| | Superparamagnetic iron oxide: pharmacokinetics and toxicity | Q42146675 |
| | Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles | Q42324117 |
| | Plasmonic nanosensors for imaging intracellular biomarkers in live cells | Q42829139 |
| | Synthesis of cRGD-peptide conjugated near-infrared CdTe/ZnSe core-shell quantum dots for in vivo cancer targeting and imaging | Q42916156 |
| | Advances in platinum chemotherapeutics | Q43038502 |
| | Effective photoreduction of a Pt(IV) complex with quantum dots: a feasible new light-induced method of releasing anticancer Pt(II) drugs | Q43286059 |
| | Design of folic acid-conjugated nanoparticles for drug targeting | Q43758625 |
| | Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake | Q44054856 |
| | Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery | Q44247729 |
| | A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. | Q44395677 |
| | Semiconductor quantum dots for photodynamic therapy | Q44694894 |
| | Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. | Q45916200 |
| | The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. | Q45977543 |
| | Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs | Q46490974 |
| | Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer | Q46507139 |
| | In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation | Q46824666 |
| | Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability | Q46968303 |
| | Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group | Q46975077 |
| | Size and shape effects in the biodistribution of intravascularly injected particles. | Q47588670 |
| | Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways | Q47692769 |
| | Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging | Q47868270 |
| | Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. 1993. | Q48477863 |
| | Polyreactions--mechanisms, taxonomy, relevance | Q48800239 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer diagnosis | Q110324059 |
| P304 | page(s) | 395-418 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | CA | Q326141 |
| P1476 | title | Nanooncology: the future of cancer diagnosis and therapy | |
| P478 | volume | 63 | |